160 related articles for article (PubMed ID: 6357231)
1. "In vitro" and "in vivo" leukocyte migration inhibitory factor production in acute infectious mononucleosis patients.
Bertotto A; Gentili F; Stagni G; Zucchetti Z; Vaccaro R
Boll Ist Sieroter Milan; 1983 Jul; 62(3):281-6. PubMed ID: 6357231
[TBL] [Abstract][Full Text] [Related]
2. Serum migration inhibitory activity and monoclonal antibody-defined T-cell phenotypes in patients with acute infectious mononucleosis.
Bertotto A; Gentili F; Stagni G; Zucchetti P; Vaccaro R
Microbiologica; 1983 Jul; 6(3):221-7. PubMed ID: 6226848
[TBL] [Abstract][Full Text] [Related]
3. Production of leucocyte migration inhibitory factor (LIF) in infectious mononucleosis. Spontaneous release and lack of response to concanavalin A.
Palit J; Bendtzen K; Andersen V
Clin Exp Immunol; 1978 Jan; 31(1):66-71. PubMed ID: 639351
[TBL] [Abstract][Full Text] [Related]
4. In vitro production of leucocyte migration inhibitory factor by lymphocytes in exudative pleural effusions.
Pettersson T; Welin MG; Weber TH
J Clin Lab Immunol; 1982 Jun; 8(2):107-11. PubMed ID: 7050387
[TBL] [Abstract][Full Text] [Related]
5. [Production of the leukocyte inhibitory factor (LIF) by peripheral blood lymphocytes in vitro and LIF-like plasma activity in paraproteinemic patients].
Puppo F; Corsini G; Mangini P; Armani U; Piana A
Haematologica; 1984; 69(4):394-402. PubMed ID: 6437916
[No Abstract] [Full Text] [Related]
6. Studies on leukocyte migration inhibitory factor (LIF) produced by activated T and B cells.
Szigeti R; Rosén A
Lymphokine Res; 1988; 7(1):11-20. PubMed ID: 3283466
[TBL] [Abstract][Full Text] [Related]
7. Effect of the cryopreservation on the production of leukocyte migration inhibition factor (LIF) by lymphocytes from normal volunteers and patients with laryngeal carcinomas.
Cavallo GP; Beatrice F; Poggio E; Bussi M; Di Fortunato V; Rendine S; Sartoris A; Cortesina G
Boll Ist Sieroter Milan; 1980 May; 59(2):147-54. PubMed ID: 7006629
[TBL] [Abstract][Full Text] [Related]
8. Use of cryopreserved lymphocytes for the indirect leukocyte migration inhibition assay.
Szigeti R; Stevens D; Ernberg I; Klein G; Masucci MG; Svedmyr E; Klein E
J Immunol Methods; 1981; 46(3):369-74. PubMed ID: 6273472
[TBL] [Abstract][Full Text] [Related]
9. Hematologic differences in heterophile-positive and heterophile-negative infectious mononucleosis.
Ventura KC; Hudnall SD
Am J Hematol; 2004 Aug; 76(4):315-8. PubMed ID: 15282662
[TBL] [Abstract][Full Text] [Related]
10. Effect of histamine on leukocyte migration tests in vertebrates. II. Study of the lack of species specificity of leukocyte inhibiting factor--production inhibitor (LIF-PI).
Rigal D; Monier JC; Mohanna K
Thymus; 1983; 5(1):53-7. PubMed ID: 6342215
[TBL] [Abstract][Full Text] [Related]
11. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
Andersson J
Scand J Infect Dis Suppl; 1996; 100():72-82. PubMed ID: 8860357
[TBL] [Abstract][Full Text] [Related]
12. Specific lymphokine responses in cervical nodes of patients with laryngeal cancer.
Cortesina G; Beatrice F; Morra B; Barioglio MG; Poggio E; Bussi M; DiFortunato V; Sacchi M; Rendine S; Sartoris A
Laryngoscope; 1987 Jul; 97(7 Pt 1):843-7. PubMed ID: 3298902
[TBL] [Abstract][Full Text] [Related]
13. Lactoferrin stimulates the production of leucocyte migration inhibitory factor by human peripheral mononuclear leucocytes.
Kijlstra A; Broersma L
Clin Exp Immunol; 1984 Feb; 55(2):459-64. PubMed ID: 6365377
[TBL] [Abstract][Full Text] [Related]
14. [Examination of lymphokines in patients with hemodialysis (author's transl)].
Löcsey L; Kálmán K; Hauck M; Kakuk G
Allerg Immunol (Leipz); 1979; 25(3):211-7. PubMed ID: 162030
[TBL] [Abstract][Full Text] [Related]
15. [Production of LIF and gamma interferon in patients with ragweed-induced allergic rhinosinusitis].
Sartoris A; Beatrice F; Giordano C; Succo G; Vico F; Sorrentino R; Beatrice C
Acta Otorhinolaryngol Ital; 1986; 6(6):613-8. PubMed ID: 3109204
[No Abstract] [Full Text] [Related]
16. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
[TBL] [Abstract][Full Text] [Related]
17. Deficient lymphokine production of newborn lymphocytes.
Winter HS; Gard SE; Fischer TJ; Bryson YJ; Stiehm ER
Pediatr Res; 1983 Jul; 17(7):573-8. PubMed ID: 6225985
[TBL] [Abstract][Full Text] [Related]
18. Participation of a histamine-Sepharose-adherent subpopulation of human mononuclear cells in the production of leucocyte migration inhibition factor (LIF) in healthy children.
Reichman BL; Handzel ZT; Segal S; Weinstein Y; Levin S
Clin Exp Immunol; 1979 Sep; 37(3):562-6. PubMed ID: 389498
[TBL] [Abstract][Full Text] [Related]
19. Biologic and molecular characterization of the IgG serum blocking factor (SBF-IgG) isolated from sera of patients with EBV-induced infectious mononucleosis.
Veltri RW; Kikta VA; Wainwright WH; Sprinkle PM
J Immunol; 1981 Jul; 127(1):320-8. PubMed ID: 6263976
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
Sugaya N; Kimura H; Hara S; Hoshino Y; Kojima S; Morishima T; Tsurumi T; Kuzushima K
J Infect Dis; 2004 Sep; 190(5):985-8. PubMed ID: 15295706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
